Skip to main content
. Author manuscript; available in PMC: 2022 Jun 25.
Published in final edited form as: ACS Sens. 2021 May 31;6(6):2225–2232. doi: 10.1021/acssensors.1c00124

Figure 1.

Figure 1.

NIRF targeted imaging of human platelets and competitive inhibition studies. (A) In vitro binding affinity of TIRO-CyAl5.5 to human platelets as obtained by FRI. (B) NIRF signal was significantly blocked with an excess of competitor Tirofiban. *P < 0.05, **P < 0.001.